MET and hepatocellular carcinoma: In addition, Galectin-1 increased AXL receptor tyrosine kinase (AXL) and proto-oncogene receptor tyrosine kinase (MET) phosphorylation, which induced sorafenib resistance and affected sorafenib-mediated ferroptosis in HCC cells.